Sphera Funds Management Ltd. Eledon Pharmaceuticals, Inc. Call Options Transaction History
Sphera Funds Management Ltd.
- $363 Million
- Q2 2025
Call Options
1 transactions
Others Institutions Holding ELDN
# of Institutions
89Shares Held
36.8MCall Options Held
48.5KPut Options Held
51.3K-
Bvf Inc San Francisco, CA6.29MShares$16.7 Million0.67% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.57MShares$9.49 Million0.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.32MShares$8.83 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN2.6MShares$6.92 Million1.08% of portfolio
-
Woodline Partners LP San Francisco, CA1.67MShares$4.45 Million0.03% of portfolio
About Eledon Pharmaceuticals, Inc.
- Ticker ELDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,756,800
- Market Cap $36.6M
- Description
- Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...